Drug discovery and development in the 21st century

Unfortunately this event has been cancelled

Thursday 4 December 2008

Venue: The Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE

organised by the Royal Society of Medicine in association with FRAME and The British Pharmacological Society

Over the past few decades, there have been dramatic advances in the application of the molecular sciences to biology and medicine. One consequence of this is that post-genomic methodologies, cell culture systems, tissue engineering, biophysical techniques and computer-based procedures are increasingly applied within the sphere of drug discovery and development.

Animal models have traditionally been used to select the most suitable drug candidates for human studies. However, the relevance of paradigms based on animal pharmacotoxicology and animal disease models is now constantly being questioned, not least because of the emergence of gene-, cell- and human-specific protein therapeutics and medical nanotechnologies. These developments have highlighted the sometimes subtle, but often crucial, differences between human and animal responses to pharmacological intervention, and make the requirement for drug testing based on human systems an increasing necessity.

The aims of this symposium are to encourage dialogue between stakeholders and decision makers, with a view to identifying the future roles of scientifically-advanced and more-appropriate alternatives to animal research and testing in drug discovery and development.

Registration Details:
Fellow: £135
BPS Member: £135
FRAME Member: £135
Associate: £105
Trainee - Fellow: £95
Retired Fellow: £95
Student Members: £45
Nurse: £130
Allied Health Professional: £130
Non-Fellow: £170
Trainee: £130
Student: £60

CPD: 5 credits